Parliament Workbench
Data: Motions & questions to 19 Nov 2026 · Votes to 12 Nov 2026

Motion For Debate · S4M-00956 · Session 4

Cancer Drugs and their Availability in Scotland

Carried Lodged by Murdo Fraser Con Lodged 27 Sep 2011 Debate 29 Sep 2011

The motion

That the Parliament notes with concern the findings of the Rarer Cancers Foundation (RCF) report, Nations divided? An assessment of variations in access to cancer treatments for patients in England, Scotland and Wales, which states that there are now 23 cancer medicines not routinely available in Scotland that may be available in England through the Cancer Drugs Fund; recognises that patients in Scotland are now three times less likely than patients in England to gain access to a cancer medicine that is not routinely available; further notes the comments of the RCF that the Scottish Government has displayed a concerning degree of complacency over access to cancer treatments, and calls on the Scottish Government to set up a Scottish cancer drugs fund to be reviewed once the current pharmaceutical price regulation scheme expires.

What MSPs voted on: the motion as amended

The Conservatives’ motion was rewritten by an SNP amendment (S4M-00956.2) before this vote. A vote ‘for’ was a vote for the SNP’s wording.

That the Parliament notes
129 words removed by S4M-00956.2with concern the findings of the Rarer Cancers Foundation (RCF) report, Nations divided? An assessment of variations in access to cancer treatments for patients in England, Scotland and Wales, which states that there are now 23 cancer medicines not routinely available in Scotland that may be available in England through the Cancer Drugs Fund; recognises that patients in Scotland are now three times less likely than patients in England to gain access to a cancer medicine that is not routinely available; further notes the comments of the RCF that the Scottish Government has displayed a concerning degree of complacency over access to cancer treatments, and calls on the Scottish Government to set up a Scottish cancer drugs fund to be reviewed once the current pharmaceutical price regulation scheme expires.
S4M-00956.2 SNP notes the Scottish Government’s significant and proactive developments in policy for the introduction and uptake of new medicines and the positive endorsement of these by the Public Petitions Committee; agrees that Scotland has robust arrangements for the introduction of newly licensed clinically and cost effective medicines, including cancer drugs, through the Scottish Medicines Consortium (SMC) and Healthcare Improvement Scotland, which operate independently of the Scottish Government; notes that, in certain circumstances, there are opportunities for local clinically led consideration of SMC "not recommended" medicines for individual patients; notes that Breakthrough Breast Cancer, Myeloma UK and Macmillan Cancer Support do not agree that the Cancer Drugs Fund is a necessary policy measure in Scotland; notes that the Scottish Government is working with the UK Department of Health with regard to the introduction of value-based pricing, and welcomes the intention to improve cancer survival rates through the detect cancer early implementation plan, backed up by the investment of £30 million.

Final wording as read into the Official Report at Decision Time. The marked changes are worked out by this site from the amendment texts and match that wording.

Amendments

  1. S4M-00956.2 SNP Nicola Sturgeon Agreed vote, 102–12
  2. S4M-00956.1 Liberal Democrat Alison McInnes Fell (worked out by this site: the Presiding Officer announced it would fall if another amendment was agreed, and that one was)

Vote

1 division
  1. 29 Sep 2011
    Carried
    106 for, 12 against

Amendments

2
  1. No recorded vote
  2. Carried
    102 for, 12 against

Supporters

No MSP has added their name to this motion.

In the Official Report

3 contributions mention S4M-00956
  1. 29 Sep 2011
    Cancer Drugs
    Tricia Marwick Meeting of the Parliament

    Good morning. The first item of business is a debate on motion S4M-00956, in the name of Murdo Fraser, on cancer drugs and their availability in Scotland. I call on Murdo Fraser to move the motion and speak; he has 10 minutes.

  2. 29 Sep 2011
    Decision Time
    Tricia Marwick Meeting of the Parliament

    There are nine questions to be put as a result of today’s business.I remind members that, in relation to the debate on cancer drugs and their availability in Scotland, if the amendment in the name of Nicola Sturgeon is agreed to, the amend…

  3. 29 Sep 2011
    Decision Time
    Tricia Marwick Meeting of the Parliament

    The next question is, that motion S4M-00956, in the name of Murdo Fraser, on cancer drugs and their availability in Scotland, as amended, be agreed to. Are we agreed?Members: No.